Clinical Drug Experience Knowledgebase

anlotinib (1 trial)

bevacizumab (avastin) (1 trial)

camrelizumab (1 trial)

capecitabine (xeloda) (1 trial)

fluorouracil (efudex) (2 trials)

gimeracil (1 trial)

leucovorin (2 trials)

methotrexate (1 trial)

oteracil (1 trial)

oxaliplatin (eloxatin) (5 trials)

paclitaxel (taxol) (1 trial)

pembrolizumab (keytruda) (2 trials)

tegafur (1 trial)

irinotecan (Camptosar) (1 trial)